NanoString Technologies Inc
OTC:NSTGQ
NanoString Technologies Inc
NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. The company is headquartered in Seattle, Washington and currently employs 766 full-time employees. The company went IPO on 2013-06-26. Its core technology includes chemistries that enable the labeling and counting of single molecules. The single-molecule chemistries enable the direct detection, identification, and quantification of individual target molecules in biological samples by attaching molecular reporters to each target molecule of interest. The company uses its core technology to develop tools for scientific and clinical research. The company offers two product platforms, including nCounter Analysis System, and its GeoMx Digital Spatial Profiler (GeoMx DSP) systems. The nCounter Analysis System is used to analyze the activity of genes in a single experiment and is also used by clinicians to analyze gene activity relevant for diagnostic applications. The GeoMx DSP is used to facilitate the analysis of selected regions of a biological sample to see how gene activity vary across those regions or in certain cell types.
NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. The company is headquartered in Seattle, Washington and currently employs 766 full-time employees. The company went IPO on 2013-06-26. Its core technology includes chemistries that enable the labeling and counting of single molecules. The single-molecule chemistries enable the direct detection, identification, and quantification of individual target molecules in biological samples by attaching molecular reporters to each target molecule of interest. The company uses its core technology to develop tools for scientific and clinical research. The company offers two product platforms, including nCounter Analysis System, and its GeoMx Digital Spatial Profiler (GeoMx DSP) systems. The nCounter Analysis System is used to analyze the activity of genes in a single experiment and is also used by clinicians to analyze gene activity relevant for diagnostic applications. The GeoMx DSP is used to facilitate the analysis of selected regions of a biological sample to see how gene activity vary across those regions or in certain cell types.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
